- Investing Ideas
- French Pharmaceuticals & Biotech Nano Cap Stocks
French Pharmaceuticals & Biotech Nano Cap Stocks
Results
4
Stocks with a market cap under US$50M.
4 companies
GenSight Biologics
Market Cap: €19.2m
A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
SIGHT
€0.082
7D
-2.6%
1Y
-59.2%
Pherecydes Pharma Société anonyme
Market Cap: €14.4m
Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.
ALPHE
€2.00
7D
2.6%
1Y
-53.6%
Poxel
Market Cap: €12.0m
A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.
POXEL
€0.22
7D
-0.4%
1Y
-66.1%
Aton
Market Cap: €10.1m
Operates as a bioscience company in France.
ALTAO
€0.012
7D
0%
1Y
38.6%